Texas Heart Institute Perfusion Student Awarded Prestigious Scholarship

Texas Heart Institute School of Perfusion Technology Student, Leslie Gonzalez (Houston, Texas

Texas Heart Institute School of Perfusion Technology Student, Leslie Gonzalez (Houston, Texas)

Texas Heart Institute's Leslie Gonzalez will travel to Medellín in 2020 through a scholarship from AmSECT Perfusion Without Borders.

HOUSTON, TX, UNITED STATES, November 20, 2019 /EINPresswire.com/ — Texas Heart Institute (THI) School of Perfusion Technology student, Leslie Gonzalez, was awarded the prestigious Perfusion Without Borders scholarship and will travel with the Novick Cardiac Alliance (NCA) to Medellín, Colombia in February of 2020.

Each year, the American Society of Extracorporeal Technology (AmSECT) Perfusion without Borders (PWOB) subcommittee offers a scholarship to one perfusion student. After a rigorous application process, the winner can apply the award to a medical mission of their choice, with any organization serving a hospital abroad.

Leslie chose to travel with The Novick Cardiac Alliance, founded by Dr. William Novick, a pediatric cardiac surgeon and a professor of international child health. Leading medical teams to treat children with heart disease for more than 20 years; his passion for changing lives and providing hope for families inspires and motivates—including Leslie Gonzalez and her mentor Deborah Adams.

Deborah Lowery Adams, CCP, Associate Director of Academics and Clinical Coordinator of the Texas Heart Institute School of Perfusion Technology, traveled with Novick Cardiac Alliance to Peru, Pakistan, Iraq, and Iran and participated in similar mission trips to Bulgaria and China with the THI’s surgical fellows in past years. “Cardiac missions work is an enriching and exceptional, professional opportunity for perfusionists of all skill levels to apply their experience and refine their perspective, “according to Adams.

Leslie expects to gain perspective on global perfusion practices as a vital aspect of cardiac surgery that will prepare her for lifelong involvement in global perfusion mission work while increasing her clinical skills.

Gonzalez is a first-generation American citizen and was raised in a small, south Texas border town called Zapata, Texas, by two extremely hard-working parents who taught her compassion, respect, empathy, integrity, and above all love.

Leslie was the first in her family to graduate from college. She pursued a career in respiratory therapy and volunteered during respiratory school to work on research projects. During her practice as a respiratory therapist in the Neonatal ICU and Pediatric ICU, she had the opportunity to help teach other aspiring respiratory students. She was asked to help lecture on different topics by her alumni professors and as a clinical preceptor.

Her hard work paid off. It helped her qualify for many awards throughout her career already including a Community Service Award at the School of Allied Health Professions at UT Health Science Center in San Antonio and Women’s Faculty Leadership Award.

“Interacting with others around the world provides more than a black and white perspective. As health care providers, we should strive to be able to think in a broader spectrum, and outside of the bordered box, to better learn different methods to advance our practice professionally and grow as individuals,” said Gonzalez.

After the trip, Leslie will present her experience at the 58th Annual AmSECT Conference, Annual NCA Meeting in St. Louis and the Annual Texas Heart Institute Perfusion Conference in June. Leslie is grateful for the opportunity to give back to the global community, “One of the most significant accomplishments I feel I can do as a human can make a difference in someone’s life and, in turn, spread the chain of compassion."

About the Texas Heart Institute (THI)
The Texas Heart Institute was founded in 1962 by world-renowned cardiovascular surgeon Dr. Denton A. Cooley, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education, and improved patient care. More information about THI (@Texas_Heart) is available at www.texasheart.org.

About Perfusion without Borders (PWOB)
Perfusion Without Borders (PWOB)is a subcommittee of the American Society of Extracorporeal Technology (AmSECT) which promotes cardiac surgery missions as an extra-vocational opportunity for professional cardiovascular perfusionists and perfusion students. The PWOB committee seeks to create opportunities for the exchange of equipment, information, and techniques and to facilitate volunteer opportunities for perfusionists to give back to the global community.

About Novick Cardiac Alliance (NCA)
NCA is dedicated to improving the skills, knowledge, technology, and experience of local health-care providers in regions of the world without access to quality Pediatric Cardiac Care. NCA aims to provide comprehensive care to all children with congenital or acquired heart disease regardless of gender, ethnicity, religion, political ideation, genetic factors or economic means.

Keri Sprung
Texas Heart Institute
832-355-9591
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Nexcopy Offers Mini Size USB Duplicator

Nexcopy USB104SA USB Duplicator

Nexcopy mini size USB Duplicator

Nexcopy Inc.

Nexcopy Inc.

Nexcopy Inc., a leading manufacturer and developer of flash memory duplicators, introduces the USB104SA, a 4 target standalone mini size USB Duplicator.

What I like about this unit is our feature rich firmware. We did not compromise on firmware and offer less. We offer the same functionality as our larger standalone USB duplicator models.”

— Greg Morris

LAKE FOREST, CA, USA, November 20, 2019 /EINPresswire.com/ — Lake Forest, CA – November 20, 2019 – Nexcopy Inc., a leading manufacturer and developer of flash memory duplicators, introduces the USB104SA, a 4 target standalone USB flash memory Duplicator specifically design to be light weight and portable.

“With the lack of optical drives in computers and laptop, the USB stick continues to grow in popularity,” reports Greg Morris, President of Nexcopy. “What we have seen is a demand for both small configuration systems for those transitioning from optical media to USB media and large production systems which we’ve serviced for years. The USB104SA is a great stepping stone for those coming from the optical duplication industry.”

The USB104SA USB Duplicator has a list of features which pivot from the larger, award winning, Nexcopy standalone duplicators. Features include:

– Asynchronous copy mode, all the time
– Binary copier will copy any format; FAT, FAT32, exFAT, NTFS, HFS, Ext2,3,4, Proprietary
Binary CRC verification algorithm
– Quick Erase and Ful Erase for disk sanitization
– Four language modes in LCD menu
– USB speed benchmark utility
– Firmware upgradeable

Stan McCrosky, head of Sales, comments, “What we have seen, are small organizations and business requesting something low cost and low volume for data duplication. Our main focus is still business-to-business, but the growing demand for low volume duplication equipment justified the development of a product like the USB104SA.”

The USB104SA is a portable solution and ideal for trade shows or spoken word events. The unit weighs less than one pound and with a foot print of about six inches by one inch tall. The unit can easily fit into your computer bag, which is ideal for carry-on luggage at the airport.

The USB duplicator is powered by a microUSB cable which can be connected to your computer laptop USB port. A USB block is also provided for powering from an outlet.

“What I like about this unit is the feature rich firmware. We did not compromise on the firmware settings and offer less. We offer the same functionality as our larger standalone USB duplicator models.” Morris continues, “For those wanting to copy USB hard drives, we do encourage them to upgrade to our USB115SA or USB131SA standalone duplicators. Those units have the proper power configuration for what the USB hard drives will require.”

Nexcopy firmware is a code technology which has evolved since 2008. This system is backward compatible with USB 1.0, 2.0 and 3.0 flash memory. The system will accept SD card reader adapters, microSD and CF card reader adapters. The firmware may be used to speed test flash memory which is a great tool for understanding the quality of flash memory a supplier has provided.

The USB104SA has four languages for the menu system. English, Spanish, Portuguese and Simplified Chinese. The menu has a back lite 2×20 screen and provides multiple settings for performance and status feedback.

The USB104SA is a 1 master to 4 target system.

Product Information:

Part Number: USB104SA
Description: 5 Port Standalone USB Duplicator 1 Master to 4 Target Configuration, no PC required, USB cable powered. Not suited for hard drives.

Hi-Resolution Product Image:
USB104SA:
http://www.nexcopy.com/downloads/USB104SA.png

https://www.nexcopy.com/usb-duplicator/usb-duplicator-standalone-usb104sa/

Availability:
For data transfer rates and speed benchmark information please contact Nexcopy Inc. or contact one of its authorized resellers. Nexcopy's complete line of USB-C Duplicators, USB Duplicators, SD Duplicators, microSD Duplicators and CF Duplicators are available through a world-wide network of authorized resellers.

Cyrus Riahi
Nexcopy Incorporated
+1 949-481-6478
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Dr Stephen Shore speaks at Shema Kolainu – Hear Our Voices Workshop: Senses and Sensibilities

Autism Workshop Discussion

Audience Members participate in discussion at the Hear Our Voices workshop series

Breakout Discussion at the Shema Kolainu Autism Workshop

Dr. Stephen Shore leads discussion with audience members at the Hear Our Voices workshop series

Dr. Stephen gives instructional and interactive videos to help participants learn how they could help alleviate the sensory issues caused by sensory overload and sensory seeking behaviors

Dr. Stephen Shore leads the workshop on sensory disorders

TOURO COLLEGE, NEW YORK, UNITED STATES, November 20, 2019 /EINPresswire.com/ — The Shema Kolainu workshop series on November 19th, 2019 was presented by Dr. Stephen Shore, a Clinical Assistant Professor at Adelphi University in New York and a member of the ICARE4Autism Advisory Committee. He gave participants an inside view on recognizing and supporting individuals with sensory issues. Dr. Shore’s workshop focused on the variation of perception of sensory stimuli that we all experience. More specifically, how individuals with autism can experience discomfort from sensory overload, and how information received may not be usable. During this workshop participants were able to experience what sensory overload may feel like as well as learning how to develop and implement accommodations to help alleviate sensory issues caused by sensory overload and sensory seeking behaviors.

This autism workshop was one of many sponsored by Shema Kolainu – Hear Our Voices, a model school, and center for children with autism and related developmental disorders. The workshop was a great success with over 100 participants including parents, specialists, and service providers. The workshop included group interactions, videos, and simulations to help participants better understand sensory differences.

Shema Kolainu – Hear Our Voices was founded by Dr. Joshua Weinstein and offers a broad spectrum of evidence-based education and therapeutic programs to children with Autism Spectrum Disorder (ASD) and related disabilities in a warm and nurturing environment. Shema Kolainu – Hear Our Voices is a nonpublic, nonprofit, nondenominational, multi-cultural school, which provides quality treatment, education, professional training and mentoring.

Suri Gruen, Program Director and Gili Rechany, Educational Director coordinated the workshop. The New York City Council Autism Initiative provided necessary funds for this workshop.

Upcoming events:

Shema Kolainu works in collaboration with ICARE4Autism which is hosting the annual International ICARE4Autism Conference on December 17th, 2019 at the Albert Einstein College of Medicine. Be sure to purchase your tickets to attend this exciting and educational conference titled: Cannabinoids, Medical Cannabis, Neurodiversity and Autism.

Tickets for the conference can be purchased here: PURCHASE TICKETS HERE

Shema Kolainu’s next workshop will be held on January 30th, 2020 with Tzirel L. Soloff. The workshop will focus on emotional regulation to help participants to learn the levels of dysregulation and how to implement necessary tools. Participants will also explore emotional regulation plans and learn how to individualize plans and skills to be used in the classroom and in the home. More information on the upcoming workshop is available at https://www.shemakolainu.org/.

Allison Kuschel
Shema Kolainu- Hear Our Voices
+1 718-686-9600
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

ImageBiopsy Lab: First US Medical Device Approval for Austrian AI Company

VIENNA, AUSTRIA, November 20, 2019 /EINPresswire.com/ — ImageBiopsy Lab announces that in November 2019, the first AI (Artificial Intelligence)-based algorithm for radiology applications developed by an Austrian medical AI start-up has received FDA (510K) clearance. With this approval, the medical AI software KOALA (Knee Osteoarthritis Labelling Assistant) can now be commercially offered in the leading global healthcare market USA.

KOALA objectifies the common radiological parameters of knee osteoarthritis (OA). Of this protracted and debilitating disease, 70 million patients worldwide are affected. KOALA fully automatically assesses the radiological parameters that are critical for the diagnosis of OA and thus delivers an objective reading-support within seconds. The software blends seamlessly into the existing radiological environment, benefiting both medical staff and patients.

Already approved as a medical device in Europe, the software offers clinicians a number of significant simplifications in the diagnosis of this common bone and joint disease: consistent diagnostic accuracy and objectivity enable standardized and detailed radiological follow-ups. This is particularly important for the early detection and monitoring of the disease, which often progresses for decades.

CEO Richard Ljuhar regards this not only as an award for his company, but also as a great recognition for the entire Austrian start-up scene: "We are quite happy that an Austrian start-up is one of the first European companies to receive clearance for such complex AI-based software". Ljuhar would also like to thank the long-standing supporters, investors and the entire ImageBiopsy Lab Team.

Future market: USA
The current FDA-approved AI algorithms come mainly from industry leaders such as General Electric (GE) and Siemens Healthineers, as well as well-funded start-ups such as Zebra Medical and AiDoc (both Israel). ImageBiopsy Lab is currently ranked among the top 20 FDA approved algorithms in radiology worldwide and continues to position itself as a leader in musculoskeletal (MSK) radiology with one of the first approved AI algorithms in this discipline. With this FDA approval, the start for the market entry into the US has been made possible: the world's largest radiological conference (RSNA) will take place in early December 2019 in Chicago and is considered the official start for entry into the US. However, Ljuhar reiterates his intention to further expand our current headquarter in Vienna but to also focus on setting up a local subsidiary company in the US.

About ImageBiopsy Lab (November 2019)
ImageBiopsy Lab (IB Lab GmbH) was founded in 2016 as a spin-off of the medical technology company Braincon Technologies in Vienna. 16+ software engineers, physicians, and scientists are committed to fundamentally changing the processes, efficiency, and quality in radiology based on AI.

IB Lab is developing a novel, AI-supported modular software platform for a standardized and objective analysis of medical images. The modules of this technology platform identify/extract key radiological disease parameters that are critical for the prevention and treatment of various bone diseases. Using KOALA as an example, it is thus possible to provide a reliable support in reading knee X-ray, used by more than 50 sites worldwide every day. Additional modules for the hip and hand modules are also in use and will be submitted later this year for the FDA review. The vision to develop and certify a focused software platform for bone diseases also convinced well-known investors such as APEX Ventures and the AWS Gruenderfond, which have been on board since December 2018 as investors and fully support the further strategy of IB Lab.

Richard Ljuhar
ImageBiopsy Lab
+43 1 9051206
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

FIRST OF ITS KIND WELLNESS PRODUCT IN FORMULATION BY JETBLACK CORP (JTBK)

More in depth details now available about this unique product

Jetblack Corp. (OTCMKTS:JTBK)

CHICAGO, ILLINOIS, USA, November 20, 2019 /EINPresswire.com/ — Jetblack Corp. (OTC: JTBK) “The Company” “JTBK” reported more in depth details on their “first of its kind” wellness product in formulation. As a background, the recent identification of cannabinoid receptors, CB1 and CB2 receptors and their endogenous lipid ligands has started an exponential growth of studies exploring the endocannabinoid system and its regulatory functions concerning health and disease.

In the past decade, the endocannabinoid system has been implicated in a vast number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, regulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a vast range of disparate diseases and pathological conditions.

Jetblack Corp. has been formulating a product which helps flush or cleanse the endocannabinoid system and CB1 and CB2 receptors to make marijuana and its cannabinoids more effective. The more a person smokes or ingests marijuana, there becomes a diminishing rate of effectiveness compared to an individual who consumes cannabis less regularly. If an individual is a regular consumer of marijuana, the effects are much milder and less effective than someone who ingests less regularly. Often heavy users complain about never getting “high”, barely feeling anything, or needing concentrates to get the desired effects. At a certain point for the regular user, even the concentrates will have little effect. In comparison to a user who consumes cannabis less regularly, will feel much greater effects of the cannabis once consumed.

According to New Frontier Data. In 2017, statistics have shown roughly 12% of the adult population in the US consume marijuana daily, while 11% of the adult population uses it weekly. In 2018, overall sales of legal marijuana in the US was greater than 9 billion dollars.

JTBK’s product helps flush the endocannabinoid system and receptors so that a regular user can use less marijuana and be acutely more effective for the goals they would like to achieve. Potentially this will save the consumer money by using less marijuana products, have greater effectiveness for their desired effect, along with less unwanted side effects that marijuana gives by consuming less cannabis. A marijuana medical patient may also benefit greatly from this product by making the marijuana much more effective for relief of their conditions.

For someone that is looking to stop consuming cannabis for whatever reason, this product may also help to clear your system for “weening off” of the cannabis. Sometimes heavy users will have some unwanted side effects from suddenly stopping consumption. Some individuals may suffer a loss of appetite from suddenly stopping consumption. Along with, irritability and a restless sleep to name a few. Often a regular user who stops consumption for 2 weeks may still up to 500 nanograms or more in their system. Sometimes a regular user will need up to 60 days to clear their system completely. Our product may help clean out the system much faster, which will give less side effects to the individual in the “weening” process.

The endocannabiniod system is still being studied, and research is in its infancy. The company believes this product may also benefit non-cannabis users as well, as we know now the endocannabinoid system plays an important role in our health. “This is why we have stated this is a wellness product from the beginning. We look forward to put the final touches on the formulation, begin test trials, along with manufacturing and production.” explained the CEO of Jetblack Corp. Daniel A. Goldin.

More information about Jetblack Corp. can be found at its website:
www.Jetblackcorp.com and its twitter handle @jetblackcorp

Information regarding investments or financing may be directed to
1-888-611-5825 by leaving a detailed message or by sending an email to:
info@jetblackcorp.com

Disclaimer:

This press release contains forward-looking statements. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward- looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties include market risks associated with our business, the inability to raise enough capital to complete our business, economic conditions and increasing competition. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The loss of key employees would be detrimental to the company success. Currently the company is considered a penny stock, which means the spreads can be very far apart, sometimes illiquid, and investors may not be able to sell when they want or for the price paid. In some circumstances the investor may lose all their investment.

Source:
Jetblack Corp
Emilia S. Olvera
1-888-611-5825
ir@jetblackcorp.com

Disseminated by:
DG Ventures, Inc.
IR Provider for Jetblack Corp.
1-800-321-9490
ir@dgventuresinc.com

Media Services
DG Ventures, Inc.
800-321-9490
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

Justin Drach: Florida-based Attorney Fighting Widespread Abuses in the Psychiatric Industry

Nearly 150 CCHR supporters gathered for the Premiere Party of the Voices for Humanity Episode on Justin Drach at the Fort Harrison Grand Auditorium.

Nearly 150 CCHR supporters gathered for the Premiere Party of the Voices for Humanity Episode on Justin Drach at the Fort Harrison Grand Auditorium.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

A new documentary features the work of attorney and mental health activist Justin Drach and his fight to protect human rights.

Florida is a target-rich environment for psychiatrists and corporations that are looking to squeeze profits from filled beds.”

— Diane Stein, President CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, November 20, 2019 /EINPresswire.com/ — Every year hundreds of thousands of people are taken into custody for involuntary psychiatric examination across the state of Florida. Called a Baker Act, the rampant abuse of rights under this law contributes to tens of millions of dollars in fraudulent billing. In a new documentary in “The Voices for Humanity” series on the Scientology TV network, attorney Justin Drach takes on the widespread illegal involuntary examination of men, women and children in Florida. Working directly with the Citizens Commission on Human Rights (CCHR), Justin Drach, a former Navy pilot, flies all over Florida seeking the safe release of countless individuals being held unjustly under the Baker Act.

“Today, in Florida, one of the greatest evils is fraudulent Baker Acts,” Drach states. “I make no bones about it, there is an epidemic of greed and abuse in medicine, especially the treatment of mental illness.”

Drach spent 10 years as a Naval aviator, including a tour of duty in Iraq. After military service, he earned his law degree and along with Amanda Thoele quickly established a prominent practice in Florida. His expertise—battling involuntary examination and potential involuntary commitment carried out by the psychiatric industry under the state’s infamous Baker Act. A strategic alliance with CCHR, a watchdog organization that exposes abuse in the mental health industry, has thrust Justin to the forefront of a movement fighting Baker Act violations. Through the specialized Baker Act Defense Attorney Symposium and Summit, known by the acronym BADASS, Drach helps to educate other attorneys in the art of securing freedom for Baker Act victims.

In support of Mr. Drach’s work, CCHR hosted an event on Wednesday 13 November at the historic Fort Harrison for the premiere of the documentary, “Wings of Justice” where the audience was appalled to learn of the horrific abuses perpetrated under the Baker Act and inspired to take action to help restore human rights.

According to Diane Stein, President of CCHR Florida, Florida is a target-rich environment for psychiatrists and corporations that are looking to squeeze profits from filled beds.

“Florida’s mental health act is weak and due process is virtually non-existent, said Stein. “Patients are bullied into submitting to ‘voluntary’ treatment all to avoid the bare minimum scrutiny of courts making people like Mr. Drach invaluable in the fight to end mental health human rights abuse in Florida.”

Ms. Stein, who is also featured on the Voices for Humanity series for her work in exposing unjust involuntary psychiatric examination of children and other mental health human rights abuses, encourages the friends and family of anyone who has suffered abuse in the mental health industry to submit a report at CCHR – www.cchrflorida.org.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969.

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Voices for Humanity: Justin Drach, Naval Aviator & Attorney (Trailor)


Source: EIN Presswire

ArangoDB Joins Cloud Native Computing Foundation

ArangoDB joins CNCF to continue its focus on providing a scalable native multi-model database

It is a natural choice for us to contribute to the Kubernetes and CNCF ecosystem which lets developers and their teams run even complex microservice architectures in a simpler way.”

— Claudius Weinberger, CEO and co-founder of ArangoDB

SAN FRANCISCO AND COLOGNE, USA AND GERMANY, November 20, 2019 /EINPresswire.com/ — ArangoDB and the Cloud Native Computing Foundation (CNCF) announced today, that the leading open-source multi-model database, ArangoDB, is now a member of the foundation behind some of the most popular open-source projects like Kubernetes (https://kubernetes.io/), Prometheus (https://prometheus.io/), Fluentd (https://www.fluentd.org/) or Rook (https://rook.io/).

By uniting graph, document, and key/value data models, along with a full-text search in one core and one query language, ArangoDB already gives developers flexibility and efficiency when building their applications. With integrations into modern orchestration systems like Kubernetes, ArangoDB continues to expands its simplicity mission to DevOps and DataOps.

Since 2015, ArangoDB committed itself to the era of modern orchestration systems and more efficient ways of deploying and running even complex applications. ArangoDB has been the first fully-certified database for Mesosphere (now D2iQ) and published one of the first Kubernetes operators including support for persistent volumes for allowing developers to run stateful applications on Kubernetes.

These early commitments also created the technical foundation to the recently released cloud service ArangoDB Oasis (https://www.arangodb.com/2019/11/arangodb-oasis-a-fully-managed-multi-model-database-service/), which uses Kubernetes and many other CNCF projects to allow managing hundreds of ArangoDB deployments on various cloud providers like GoogleCloud, AWS and Azure efficiently and securely.

“The whole idea of a native multi-model database is to provide a better way of creating applications” said Claudius Weinberger, CEO and co-founder of ArangoDB and added “It is a natural choice for us to contribute to the Kubernetes and CNCF ecosystem which lets developers and their teams run even complex microservice architectures in a simpler way. We are excited about the future of Kubernetes and to even better share our learnings, ideas and code with the community by joining the CNCF.”

Learn more:
– For more details about ArangoDB joining CNCF: Read the blog https://www.arangodb.com/2019/11/arangodb-and-the-cloud-native-ecosystem/
– How Kubernetes is used in ArangoDBs managed service Oasis: Read the blog https://www.arangodb.com/2019/10/how-we-build-our-managed-service-on-kubernetes/

About ArangoDB:
One database, one query language, and three data models. With more than 7 million downloads and over 8,000 stargazers on GitHub (https://github.com/arangodb/arangodb), ArangoDB is the leading open source native multi-model database. It combines the power of graphs with JSON documents, a key-value store, and a full-text search engine, enabling developers to access and combine all of these data models with a single, elegant, declarative query language. Now also available as fully managed cloud service, ArangoDB Oasis (https://cloud.arangodb.com/home).

Simplifying complexity and increasing productivity is the mission of ArangoDB Inc., the company behind the project. Founded in 2014, ArangoDB Inc. is a privately-held company backed by Bow Capital and Target Partners. It is headquartered in San Francisco and Cologne with offices and employees around the world. Learn more at www.arangodb.com.

Jan Stücke
ArangoDB Inc.
+49 221 272299960
email us here


Source: EIN Presswire

Wearable Medical Devices Market Major Manufacturers, Trends, Demand, Share Analysis to 2025

New Market Study, Report "Wearable Medical Devices Market 2019 Global Market Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2025".

PUNE, MAHARASHTRA, INDIA, November 20, 2019 /EINPresswire.com/ — Wearable Medical Devices Market 2019-2025

New Market Study, Report "Wearable Medical Devices Market 2019 Global Market Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2025" Has been Added on WiseGuyReports.com.

Report Summary:

Wearable Medical Devices Market to Witness an Upward Trend

This report provides in depth study of “Wearable Medical Devices Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Website Wearable Medical Devices Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The wearable devices are becoming popular among the patients as well as doctors community around the globe. As the total populace is maturing and ceaseless maladies are on the ascent, the human services industry is quickly conveying innovative arrangements. The expansion of innovative therapeutic electronic gadgets and wearable hardware is incredibly improving patient results and decreasing social insurance costs. Associated patient demonstrating will be a basic factor in the proceeding with achievement of this field. The exponentially developing interest for associated medicinal gadgets is relied upon to arrive at 20 billion by 2020. There are many factors that drive the growth of the wearable device market in the world. The devices of remote patient monitoring and home health care are driving the growth of the wearable device market worldwide.

High pervasiveness way of life related issue, for example, diabetes and hypertension, requires consistent observing of a few physiological parameters, for example, glucose levels and circulatory strain, because of inactive way of life. This permits amalgamation of medicinal services information with convenient gadgets, which can be sent to doctors for ongoing access to information and insignificant mistakes. In addition, rising death rate due to non-transferable maladies is the significant concern requesting more spotlights on customized observing and care. Ultimately, this is expected to boost the demand further. There are several governments who are constantly making awareness campaign for people all around the globe. Growing pervasiveness of mortality rate along with chronic disease have become major concerns among government organizations as well as people across the world.

People nowadays are becoming aware about their health. The awareness of physical fitness has enabled the people in a large way. The people can track their fitness level by wearing fitness and medical devices. They can wear smart watches and smart band for tracking the fitness level. The wearable devices can be used as per the instruction of physicians and psychiatrist. The market of wearable devices has been grown leaps and bounds in key markets of the world. As per the market researcher, the market would achieve the double size of the present market

Request for Free Sample Report of “Wearable Medical Devices” Market @  https://www.wiseguyreports.com/sample-request/4412851-global-wearable-medical-devices-market-professional-survey-report-2019

Important key Players Analysis: Fitbit, Philips, Garmin, Omron, Drägerwerk, Nokia Technologies, Jawbone, Polar Electro, World Global Network [Wor(I)D], Activeinsights, Vitalconnect, Xiaomi, Misfit, Monica Healthcare and more.

Market Segmentation

The usage of the wearable device has become diverse and unique in every corner of the world. The market of wearable device has been segmented into three ways such as device type, segment type and application. The segment of the wearable device is segmented into four forms such as smart watches, activity monitors, patches and smart clothing. There are multiple types of wearable medical devices present in the market such as therapeutic devices and monitoring and diagnostic devices. The devices can be distributed through various channels such as hypermarkets, pharmacies and online. The device can be used in different application such as remote patient monitoring, home healthcare, and sports fitness and academies.

Geographical market classification

Let’s have a view over the international market. The USA, the UK, France, Germany, Canada, Mexico, Russia, China, India, Japan, Australia, New Zealand, South Africa, Egypt, Nigeria, Central and Latin America.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/4412851-global-wearable-medical-devices-market-professional-survey-report-2019

Latest News

Many prominent companies that are creating advanced medical devices for meeting the needs of the patients worldwide.

Continued….

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Global Patient Monitoring Systems Market Report 2019-2025 by Technology, Opportunities, Top Key Players and more…

A new market study, titled “Global Patient Monitoring Systems Market Professional Survey Report 2019”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, November 20, 2019 /EINPresswire.com/ — Patient Monitoring Systems Market

The global Patient Monitoring Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Patient Monitoring Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Patient Monitoring Systems market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Patient Monitoring Systems in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Patient Monitoring Systems manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Ge Healthcare
Medtronic
Philips Healthcare
Lifewatch
Nihon Kohden
Omron Corporation
Honeywell International
Bard Medical
Welch Allyn
Infinium Medical
Delta
Syncro Medical

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4632467-global-patient-monitoring-systems-market-professional-survey-report-2019

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hemodynamic Monitoring Systems
Neuromonitoring Systems
Cardiac Monitoring Systems
Fetal and Neonatal Monitoring Systems
Respiratory Monitoring Systems
Others

Segment by Application
Hospitals
Home
Clinics

Table of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst's Viewpoints/Conclusions
15 Appendix

View Detailed Report at https://www.wiseguyreports.com/reports/4632467-global-patient-monitoring-systems-market-professional-survey-report-2019

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Hair Transplant Market 2014 Global Analysis, Size, Share, Growth, Trends & Forecast To 2026

Wiseguyreports.Com Adds “Hair Transplant– Global Market Share, Industry Analysis, Competitive Landscape, Strategies And Forecast To 2026”

PUNE, MAHARASTRA, INDIA, November 20, 2019 /EINPresswire.com/ — Hair Transplant Market 2014-2026

Report Overview:

A study on the global HAIR TRANSPLANT market reveals a detailed report about the progress, current state, and future forecast of the market. The objective of the market study is to define, segment, describe, and forecast the market as per various pre-defined categories. The report offers an overview of the competitive landscape of the HAIR TRANSPLANT market and profiles an extensive list of companies operating in the industry. The players are analyzed, shortlisted, and narrowed down in terms of their financial stability, revenue generation, product portfolio, and the various strategies employed to maintain or attain market growth.

Major Companies Covered:

The global HAIR TRANSPLANT market includes various leading players who are making consistent efforts to stand atop the market standings and lead the competitive rankings.

PhotoMedex Inc.
Hair Transplants of Florida
Hair Restoration Blackrock HRBR getFUE Hair Clinics Ltd.
MEDICAMAT
Bernstein Medical
Lumenis Inc.
Solta Medical Inc.
L'Oreal SA
The Acibadem Hospitals Group
Allergan Plc.
ILHT Dubai
Bosley
Limmer Hair Transplant Center
Restoration Robotics Inc.
The Hairline Clinic
Hair Transplant Center Turkey

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4210703-2014-2026-global-hair-transplant-industry-market-research

If you have any special requirements, please let us know and we will offer you the report as you want.

Market Dynamics:

The report even analyzes the core competencies of the profiled players and the percentage of share they are contributing to the overall market. This is done so as to gain an idea about the state of competition in the market. The report comprises study of the various competitive developments being made in the market like partnerships, collaborations and acquisitions, research and development activities, investments, product introductions, and so on. For the report to offer a comprehensive and acute data about the current and potential state of the market, a forecast period was ascertained. This was done by considering 2014 as the base year of the forecast period and 2026 as the end year. The primary goal of the report is to aid the stakeholders with insightful answers about the market for them to make precise and comparatively accurate investment decisions in the coming years.

Market Segmentation:

The segmentation of the global HAIR TRANSPLANT market is a key aspect of the study. The report effectively distributes the market as per different categories and segments and assesses the probable growth of each of the segments over the defined forecast period.

Regional Description:

A big part of the market segmentation includes the regional segmentation. The global HAIR TRANSPLANT market was geographically distributed across some of the leading regions around the world. The market was thoroughly analyzed and the potential growth was determined across each of these regions to enable a precise geographic understanding of the industry.

Research Methodology:

The methodology applied for the research of the global HAIR TRANSPLANT market comprised data capturing of the revenue that is being generated by the players operating in the market through a number of secondary sources.

Table of Contents:

1 Introduction

2 Key Findings of the Study

3 Market Dynamics

4 Value Chain of the Hair Transplant Market

5 Global Hair Transplant Market-Segmentation by Type

6 Global Hair Transplant Market-Segmentation by Application

7 Global Hair Transplant Market-Segmentation by Marketing Channel

8 Competitive Intelligence – Company Profiles

9 Global Hair Transplant Market-Segmentation by Geography

Continued…..

Enquiry Before Buying @ https://www.wiseguyreports.com/enquiry/4210703-2014-2026-global-hair-transplant-industry-market-research

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here


Source: EIN Presswire